References
- Ballantyne JC , MaoJ. Opioid therapy for chronic pain. N. Engl. J. Med.349(20) , 1943–1953 (2003).
- Eriksen J , Sj⊘grenP, BrueraEet al. Critical issues on opioids in chronic non-cancer pain: an epidemiological study. Pain 125(1–2) , 172–179 (2006).
- Chapman CR , LipschitzDL, AngstMSet al. Opioid pharmacotherapy for chronic non-cancer pain in the United States: a research guideline for developing an evidence-base. J. Pain 11(9) , 807–829 (2010).
- Furlan AD , SandovalJA, Mailis-GagnonAet al. Opioids for chronic noncancer pain: a metaanalysis of effectiveness and side effects. CMAJ 174(11) , 1589–1594 (2006).
- Kalso E , EdwardsJE, MooreRAet al. Opioids in chronic non-cancer pain: systematic review of efficacy and safety. Pain 112(3) , 372–380 (2004).
- Chou R . Clinical Guidelines from the American Pain Society and the American Academy of Pain Medicine on the use of chronic opioid therapy in chronic noncancer pain. Pol. Arch. Med. Wewn.119(7–8) , 469–477 (2009).
- Bruehl S , ApkarianAV, BallantyneJCet al. Personalized medicine and opioid analgesic prescribing for chronic pain: opportunities and challenges. J. Pain 14(2) , 103–113 (2013).
- Tremblay J , HametP. Genetics of pain, opioids, and opioid responsiveness. Metabolism59(Suppl. 1) , S5–S8 (2010).
- Ballantyne JC . Opioids for chronic nonterminal pain. South Med. J.99(11) , 1245–1255 (2006).
- Noble M , TreadwellJR, TregearSJet al. Long-term opioid management for chronic noncancer pain. Cochrane Database Syst. Rev. 1 , CD006605 (2010).
- H⊘jsted J , Sj⊘grenP. Addiction to opioids in chronic pain patients: a literature review. Eur. J. Pain11(5) , 490–518 (2007).
- Sj⊘gren P , EkholmO, PeuckmannVet al. Epidemiology of chronic pain in Denmark: an update. Eur. J. Pain 13(3) , 287–292 (2009).
- Nogueiras R , Romero-PicoA, VazquezMJet al. The opioid system and food intake: homeostatic and hedonic mechanisms. Obes. Facts 5(2) , 196–207 (2012).
- Chen L , MalarickC, SeefeldLet al. Altered quantitative sensory testing outcome in subjects with opioid therapy. Pain 143(1–2) , 65–70 (2009).
- H⊘jsted J , KuritaGP, KendallSet al. Non-analgesic effects of opioids: the cognitive effects of opioids in chronic pain of malignant and non-malignant origin. An update. Curr. Pharm. Des. 18(37) , 6116–6122 (2012).
- Lennon FE , MossJ, SingletonPA. The mu-opioid receptor in cancer progression: is there a direct effect? Anesthesiology116(4) , 940–945 (2012).
- Bortsov AV , MillikanRC, BelferIet al. Mu-opioid receptor gene A118G polymorphism predicts survival in patients with breast cancer. Anesthesiology 116(4) , 896–902 (2012).
- Katz N , MazerNA. The impact of opioids on the endocrine system. Clin. J. Pain25(2) , 170–175 (2009).
- Abs R , VerhelstJ, MaeyaertJet al. Endocrine consequences of long-term intrathecal administration of opioids. J. Clin. Endocrinol. Metab. 85(6) , 2215–2122 (2000).
▪ Website
- National Prescribing Service Limited. Clinical audit: review of opioid prescribing in chronic pain (2010). www.nps.org.au/__data/assets/pdf_file/0006/89160/Clinical_Audit_sample_pack-no_enrolment.pdf (Accessed 5June2013)